GOTHIKA

Experiment Log: Subject S – Prisoner #1443 (Codename: “The Vipress”)

Date: [REDACTED]

Lead Researcher: Dr. Richard Moore

Facility: Blackmoor Institute for the Criminally Insane

Experiment ID: RIZE-EX-105-S

Objective:

Administer initial doses of the experimental drug “Rize” to assess its effectiveness in breaking down the subject’s mental defenses to allow for direct mind control by external sources. Monitor physical and psychological responses, including emotional vulnerability, magical shifts, and signs of invisibility. Evaluate potential for subject to become a controllable asset.

Subject Details

Name: [REDACTED]

Age: Unknown

Gender: Female

Criminal Record: Alleged involvement in organized crime

Mental State: Emotionally resilient, strong-willed, manipulative tendencies detected. No known history of psychological disorders. Subject exhibits high resistance to influence.

Phase 1 - Initial Administration:

Dosage: 5 mg of Rize, intravenously.

Time: 10:00 hours.

Effects after 1 hour: Subject reports heightened sensitivity to sound and emotional shifts around her. Initial biomonitoring shows a minor disruption in her mental defenses, but subject remains aware of external attempts to manipulate her thoughts. Increased heart rate (120 BPM) and slight tremors noted. Magical aura detected, suggesting early signs of magical activation.

Effects after 2 hours: Subject becomes visibly agitated when exposed to hypnotic audio frequencies intended to induce submission. Emotional responses fluctuate between anger and confusion. While no overt submission is achieved, subtle behavioral shifts suggest cracks forming in the subject’s psyche. Discoloration along her forearms appears, glowing faintly under dim light.

Effects after 4 hours: Subject exhibits resistance to mental control protocols, forcibly maintaining focus despite prolonged exposure to subliminal messaging. Staff report unusual tension when engaging with her—although she is under observation, her behavior exerts an unspoken emotional influence over those nearby. Subject mutters, “I know what you’re doing,” but does not appear fully aware of the control attempts.

Phase 2 - Escalation:

Dosage: 10 mg of Rize, administered the following day.

Time: 11:00 hours.

Effects after 30 minutes: Subject begins displaying physical changes—rough patches develop along her arms and neck. Subject exhibits emotional volatility, alternating between calm calculation and violent outbursts. During heightened emotional states, portions of her limbs fade from view, though these episodes are brief and inconsistent. Hypnotic command attempts continue to meet with resistance.

Effects after 1 hour: Subject describes a disturbing sense of her mind “fracturing” under repeated attempts at control, but external control protocols remain ineffective. Subject’s fingers fade in and out of visibility during moments of heightened stress. She shows signs of emotional vulnerability, though not enough to yield to direct commands.

Effects after 3 hours: Despite multiple external attempts to penetrate her mind, the subject’s mental resilience increases. Telepathic links established by researchers are repeatedly severed as she unconsciously pushes them out. Subject complains of vivid dreams where she fights off an unseen force attempting to “claim” her mind. Her resistance is accompanied by fluctuations in magical energy, causing equipment malfunctions during testing.

Mental State: Subject’s paranoia increases, though she continues to exhibit defiance toward all staff. She expresses fear of being “lost to something” but insists that “it hasn’t taken me yet.” Though her body shows signs of physical transformation, her mind remains intact and unsubdued, forcing staff to reconsider the effectiveness of their methods.

Phase 3 - Early Signs of Mutation:

Dosage: 15 mg planned but postponed.

Time: [REDACTED].

Effects Postponed: After significant resistance to mind control, further doses were delayed to assess potential secondary effects. Subject is showing signs of magical empowerment rather than submission, complicating attempts to break her will. Early indications of invisibility and emotional manipulation appear, though these abilities remain erratic and seem involuntary.

Additional Observations: Staff report heightened emotional discomfort while interacting with the subject, suggesting she may be unconsciously influencing those around her, despite efforts to keep her under control. Telepathic synchronization attempts have become increasingly difficult. Subject’s dreams suggest she is mentally waging a battle against outside control attempts, stalling her transformation.

Preliminary Conclusion:

Subject S demonstrates unusual resistance to mind control protocols, retaining much of her mental clarity despite repeated subliminal exposure and direct telepathic influence. Attempts to break her will have instead resulted in unintended magical enhancements, including flashes of invisibility and bursts of emotional influence over staff.

Further experimentation is required to determine whether her resistance can be broken over time or if she must be terminated to prevent her powers from fully manifesting. Higher doses carry the risk of escalating her magical abilities beyond containment. Close monitoring remains essential, as the subject is becoming more volatile and increasingly dangerous to handle.

Signed:
Dr. Richard Moore
Lead Researcher, Blackmoor Institute